In honor of Women’s History Month, Johns Hopkins Bloomberg School of Public Health features nine innovators and trailblazers, including Lisa Coussens, Ph.D., whose work “led to a shift in the way we think of cancer, from a bunch of cells in isolation to considering how the surrounding microenvironment around the tumors can be exploited to develop better anti-cancer therapies.”

New OHSU research describes the science behind a promising technique to treat infertility by turning a skin cell into an egg capable of producing viable embryos. Shoukhrat Mitalipov, Ph.D., says, “Our technology would enable infertile patients to have genetically related children, providing a path to parenthood that is currently unavailable, even with IVF.”

CNBC covers research revealing OHSU among the top 10 public schools in the nation in terms of graduates’ early career salaries.

Pharmacy Learning Network covers a recent review by Erick Turner, M.D., that finds the nation’s most widely prescribed type of sedative may be less effective than clinicians and scientists have been led to believe. Turner says, “With publication bias, aka selective publication, there is a process of picking and choosing which study results do and do not get published, with the result of making the drug look better.”

Esther Choo, M.D., coauthors a column for Medpage Today that says the ethos of emergency medicine — any patient, any time, any problem — could be radically changed depending on how the U.S. Supreme Court rules on the case of U.S. v. the State of Idaho, a case that asks the question: What happens when an abortion is necessary to save the life of the mother and abortion is illegal in that state?

The Oregon Poison Center shares data on a dramatic increase in cases of young children exposed to fentanyl. The poison center managed 16 cases of illicit fentanyl exposure in children younger than 6 in 2023, an increase from just 2 in 2021 and 0 in 2020. “It is imperative that the community provides resources to end the fentanyl epidemic, and that people who use illicit drugs secure them from children by using opaque, child-resistant, lockable containers,” says Robert Hendrickson, M.D.

The Oregon Poison Center shares data on a dramatic increase in cases of young children exposed to fentanyl. The poison center managed 16 cases of illicit fentanyl exposure in children younger than 6 in 2023, an increase from just 2 in 2021 and 0 in 2020. “It is imperative that the community provides resources to end the fentanyl epidemic, and that people who use illicit drugs secure them from children by using opaque, child-resistant, lockable containers,” says Robert Hendrickson, M.D.

The Oregon Poison Center shares data on a dramatic increase in cases of young children exposed to fentanyl. The poison center managed 16 cases of illicit fentanyl exposure in children younger than 6 in 2023, an increase from just 2 in 2021 and 0 in 2020. “It is imperative that the community provides resources to end the fentanyl epidemic, and that people who use illicit drugs secure them from children by using opaque, child-resistant, lockable containers,” says Robert Hendrickson, M.D.

The Oregon Poison Center shares data on a dramatic increase in cases of young children exposed to fentanyl. The poison center managed 16 cases of illicit fentanyl exposure in children younger than 6 in 2023, an increase from just 2 in 2021 and 0 in 2020. “It is imperative that the community provides resources to end the fentanyl epidemic, and that people who use illicit drugs secure them from children by using opaque, child-resistant, lockable containers,” says Robert Hendrickson, M.D.

GI & Hepatology News covers a new white paper advocating for improved care for more than 3 million Americans living with inflammatory bowel disease. Anthony Sofia, M.D., says, “Every day, we see people who have been harmed by delayed and inadequate care. Solving these barriers would lift an unimaginable weight off our patients’ shoulders and allow them to lead healthier lives.”